Back to Primary Central Nervous System Lymphoma

Research record changes

The latest 100 trial status and retraction changes detected since change tracking began. Dates show when RareWays recorded the change, which may be later than the source update. Earlier history is unavailable.

  1. Autologous CD19-CD20-NKG2D-nsBicephali CAR-T for Relapsed/Refractory Central Nervous System Lymphoma

    SUSPENDED → WITHDRAWN

    Recorded 2026-10-14

    View record